The role of survivin splice variants in pancreatic ductal adenocarcinoma Gemcitabine resistance

被引：1
|
作者：
Kabagwira, Janviere [1 ]
Gonda, Amber [1 ]
Kwong, Mei Li [1 ]
机构：
[1] Loma Linda Univ, Loma Linda, CA 92350 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-3021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3021
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Survivin Splice Variant 2? Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine
    Fuller, Ryan N.
    Kabagwira, Janviere
    Vallejos, Paul A.
    Folkerts, Andrew D.
    Wall, Nathan R.
    ONCOTARGETS AND THERAPY, 2022, 15 : 1147 - 1160
  • [2] Gemcitabine resistance in pancreatic ductal adenocarcinoma
    Binenbaum, Yoav
    Na'ara, Shorook
    Gil, Ziv
    DRUG RESISTANCE UPDATES, 2015, 23 : 55 - 68
  • [3] Splice variants as novel targets in pancreatic ductal adenocarcinoma
    Jun Wang
    Laurent Dumartin
    Andrea Mafficini
    Pinar Ulug
    Ajanthah Sangaralingam
    Namaa Audi Alamiry
    Tomasz P. Radon
    Roberto Salvia
    Rita T. Lawlor
    Nicholas R. Lemoine
    Aldo Scarpa
    Claude Chelala
    Tatjana Crnogorac-Jurcevic
    Scientific Reports, 7
  • [4] Splice variants as novel targets in pancreatic ductal adenocarcinoma
    Wang, Jun
    Dumartin, Laurent
    Mafficini, Andrea
    Ulug, Pinar
    Sangaralingam, Ajanthah
    Alamiry, Namaa Audi
    Radon, Tomasz P.
    Salvia, Roberto
    Lawlor, Rita T.
    Lemoine, Nicholas R.
    Scarpa, Aldo
    Chelala, Claude
    Crnogorac-Jurcevic, Tatjana
    SCIENTIFIC REPORTS, 2017, 7
  • [5] Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
    Koltai, Tomas
    Reshkin, Stephan Joel
    Carvalho, Tiago M. A.
    Di Molfetta, Daria
    Greco, Maria Raffaella
    Alfarouk, Khalid Omer
    Cardone, Rosa Angela
    CANCERS, 2022, 14 (10)
  • [6] Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
    Mendes, Ines
    Vale, Nuno
    BIOMEDICINES, 2024, 12 (01)
  • [7] Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma
    L R Palam
    J Gore
    K E Craven
    J L Wilson
    M Korc
    Cell Death & Disease, 2015, 6 : e1913 - e1913
  • [8] Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
    Shao, Feng
    Huang, Mei
    Meng, Futao
    Huang, Qiang
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [9] Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma
    Palam, L. R.
    Gore, J.
    Craven, K. E.
    Wilson, J. L.
    Korc, M.
    CELL DEATH & DISEASE, 2015, 6 : e1913 - e1913
  • [10] Phosphomimetic Dicer rewires glutamine metabolism and gemcitabine resistance in pancreatic ductal adenocarcinoma
    Chiu, Ching-Feng
    Park, Ji Min
    Shen, Yu-Shiuan
    Lin, Chia-Ying
    Hsu, Tung-Wei
    Su, Yen-Hao
    Chen, Hsin-An
    CANCER RESEARCH, 2022, 82 (12)
12345